Mithril is a global technology investment firm investing in the technology, macroeconomics and finance sectors.
Business Model: B2B
Revenue: $1.7M
Employees: 2-10
Address: 600 Congress Ave.
City: Austin
State: TX
Zip: 78701
Country: US
Mithril is a family of long-term venture capital funds agnostic to sector and geography. They provide capital to leading growth companies by partnering with teams who use technology to build transformative and durable businesses.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
8/2020 | Fractyl Health | Series E | 0 |
2/2015 | AppDirect | Series D | 50M |
11/2017 | Fractyl Health | Series D | 0 |
9/2019 | Glance | Venture Round | 45M |
4/2018 | Ment.io | Venture Round | 6M |
6/2022 | Oma Fertility | Venture Round | 0 |
9/2016 | Avitide | Series D | - |
8/2022 | Fractyl Health | Series F | - |
5/2022 | GreyOrange | Debt Financing | - |
3/2022 | AiFi | Series B | 0 |
10/2013 | Lookout | Series E | 55M |
3/2021 | Flex Logix Technologies | Series D | 55M |
6/2016 | Partnerize | Series C | 15.4M |
3/2021 | ForSight Robotics | Seed Round | 10M |
7/2022 | ForSight Robotics | Series A | 0 |
8/2017 | Auris Health | Series D | 0 |
9/2020 | Treasure Financial | Seed Round | 0 |
11/2018 | Auris Health | Series E | 0 |
7/2019 | Neocis | Venture Round | 30M |
6/2021 | Generation Home | Series A | 0 |
3/2014 | Auris Health | Series A | 34.4M |
11/2015 | Fractyl Health | Series C | 57M |
9/2015 | Auris Health | Series B | 149.5M |
4/2014 | AppDirect | Series C | 35M |
9/2021 | BlackSky Global | Post-IPO Equity | 180M |
9/2014 | Palantir Technologies | Series I | 444.2M |
4/2014 | SilverRail Technologies | Series C | 40M |
8/2015 | C2FO | Series E | 0 |
2/2018 | C2FO | Series F | 100M |
12/2020 | Glance | Venture Round | 145M |
8/2014 | MagForce | Post-IPO Equity | 15M |
5/2016 | Stem | Series C | 15M |
8/2014 | Helion Energy | Seed Round | 1.5M |
9/2014 | Fractyl Health | Series B | 19.8M |
10/2022 | Neocis | Series D | 0 |
12/2020 | Paxos | Series C | 0 |
6/2015 | Classy | Series B | 0 |
6/2016 | Spaceflight Industries | Series B | 25M |
9/2014 | Partnerize | Series B | 10M |
10/2020 | Neocis | Series D | 72M |
6/2017 | Avitide | Equity | 12M |
7/2013 | C2FO | Series C | 0 |
1/2016 | Helion Energy | Series B | 21.3M |
10/2022 | Genetesis | Series C | 0 |
9/2020 | Nuvia | Series B | 240M |
11/2021 | Helion Energy | Series E | 0 |
11/2020 | Adagio Therapeutics | Series B | 0 |
10/2015 | AppDirect | Series E | 0 |
8/2014 | Lookout | Series F | 150M |
11/2016 | Classy | Series C | 0 |
8/2014 | DoubleDutch | Series D | 15M |
7/2020 | Adagio Therapeutics | Series A | 0 |
10/2022 | Juno | Series A | 0 |
11/2021 | Ankyra | Series B | 45M |
4/2021 | Adagio Therapeutics | Series C | 0 |
4/2021 | Paxos | Series D | 0 |
5/2022 | GreyOrange | Venture Round | 0 |
5/2018 | Figure | Series A | 50M |
6/2018 | Capture2 | Series A | 4M |
9/2018 | GreyOrange | Series C | 140M |
7/2022 | ForSight Robotics | Series A | 0 |
6/2022 | Oma Fertility | Venture Round | 0 |
5/2022 | GreyOrange | Debt Financing | - |
5/2022 | GreyOrange | Venture Round | 0 |
3/2022 | AiFi | Series B | 0 |
11/2021 | Ankyra | Series B | 0 |
11/2021 | Helion Energy | Series E | 0 |
9/2021 | BlackSky Global | Post-IPO Equity | 0 |
6/2021 | Generation Home | Series A | 0 |
4/2021 | Paxos | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|